Patent Number: 6,251,926

Title: Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity

Abstract: This invention provides a novel oxyiminoalkanoic acid derivative which has excellent hypoglycemic and hypolipidemic actions and which is used for the treatment of diabetes mellitus, hyperlipemia, insulin insensitivity, insulin resistance and impaired glucose tolerance.

Inventors: Momose; Yu (Takarazuka, JP), Odaka; Hiroyuki (Kobe, JP), Imoto; Hiroshi (Kusatsu, JP), Kimura; Hiroyuki (Sakai, JP), Sakamoto; Junichi (Toyonaka, JP)

Assignee: Takeda Chemical Industries, Ltd.

International Classification: C07D 215/14 (20060101); C07D 261/00 (20060101); C07D 239/00 (20060101); C07D 213/00 (20060101); C07D 261/08 (20060101); C07D 239/42 (20060101); C07D 277/24 (20060101); C07D 215/00 (20060101); C07D 277/00 (20060101); C07D 271/00 (20060101); C07D 263/32 (20060101); C07D 413/00 (20060101); C07D 213/74 (20060101); C07D 263/00 (20060101); C07D 471/00 (20060101); C07D 271/06 (20060101); C07D 413/12 (20060101); C07D 471/04 (20060101); A61K 031/424 (); A61K 031/421 (); C07D 003/06 (); A61P 029/00 ()

Expiration Date: 06/26/2018